MAHLY
Price
$17.50
Change
-$0.44 (-2.45%)
Updated
Aug 14 closing price
Capitalization
3.77B
PDRX
Price
$2.81
Change
+$0.01 (+0.36%)
Updated
Sep 3 closing price
Capitalization
N/A
Interact to see
Advertisement

MAHLY vs PDRX

Header iconMAHLY vs PDRX Comparison
Open Charts MAHLY vs PDRXBanner chart's image
Medipal Holdings
Price$17.50
Change-$0.44 (-2.45%)
Volume$367
Capitalization3.77B
PD-RX Pharmaceuticals
Price$2.81
Change+$0.01 (+0.36%)
Volume$2.2K
CapitalizationN/A
MAHLY vs PDRX Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. PDRX commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Hold and PDRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (MAHLY: $17.50 vs. PDRX: $2.81)
Brand notoriety: MAHLY and PDRX are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 36% vs. PDRX: 65%
Market capitalization -- MAHLY: $3.77B vs. PDRX: $0
MAHLY [@Medical Distributors] is valued at $3.77B. PDRX’s [@Medical Distributors] market capitalization is $0. The market cap for tickers in the [@Medical Distributors] industry ranges from $88.49B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whilePDRX’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • PDRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MAHLY is a better buy in the long-term than PDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 4 TA indicator(s) are bullish while PDRX’s TA Score has 2 bullish TA indicator(s).

  • MAHLY’s TA Score: 4 bullish, 3 bearish.
  • PDRX’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, MAHLY is a better buy in the short-term than PDRX.

Price Growth

MAHLY (@Medical Distributors) experienced а 0.00% price change this week, while PDRX (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.35%. For the same industry, the average monthly price growth was +3.86%, and the average quarterly price growth was +1.72%.

Industries' Descriptions

@Medical Distributors (+0.35% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY YTD gains are higher at: 8.865 vs. PDRX (-7.869).
MAHLYPDRXMAHLY / PDRX
Capitalization3.77BN/A-
EBITDA100BN/A-
Gain YTD8.865-7.869-113%
P/E Ratio13.35N/A-
Revenue3.6TN/A-
Total Cash251BN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MAHLY vs PDRX: Fundamental Ratings
MAHLY
PDRX
OUTLOOK RATING
1..100
3446
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
53100
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MAHLY's Valuation (50) in the null industry is in the same range as PDRX (50). This means that MAHLY’s stock grew similarly to PDRX’s over the last 12 months.

MAHLY's Profit vs Risk Rating (97) in the null industry is in the same range as PDRX (100). This means that MAHLY’s stock grew similarly to PDRX’s over the last 12 months.

MAHLY's SMR Rating (53) in the null industry is somewhat better than the same rating for PDRX (100). This means that MAHLY’s stock grew somewhat faster than PDRX’s over the last 12 months.

MAHLY's Price Growth Rating (50) in the null industry is in the same range as PDRX (50). This means that MAHLY’s stock grew similarly to PDRX’s over the last 12 months.

MAHLY's P/E Growth Rating (62) in the null industry is somewhat better than the same rating for PDRX (100). This means that MAHLY’s stock grew somewhat faster than PDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYPDRX
RSI
ODDS (%)
Bearish Trend 1 day ago
43%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
46%
Bearish Trend 1 day ago
19%
Momentum
ODDS (%)
Bullish Trend 1 day ago
34%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
44%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
32%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
37%
Bullish Trend 1 day ago
28%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
33%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
PORTO.X1.0628510.015324
+1.46%
FC Porto Fan Token cryptocurrency
VFS3.280.01
+0.31%
VinFast Auto Ltd
OPHC4.25N/A
N/A
OptimumBank Holdings Inc
STBA39.05-0.35
-0.89%
S&T Bancorp
ALT3.64-0.05
-1.36%
Altimmune

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and ZYXI have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
ZYXI - MAHLY
5%
Poorly correlated
-3.90%
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
N/A
COSM - MAHLY
2%
Poorly correlated
+11.38%
More

PDRX and

Correlation & Price change

A.I.dvisor tells us that PDRX and NSVGF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDRX and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDRX
1D Price
Change %
PDRX100%
N/A
NSVGF - PDRX
8%
Poorly correlated
N/A
MAHLY - PDRX
2%
Poorly correlated
N/A
SHPMY - PDRX
0%
Poorly correlated
N/A
ARRJF - PDRX
0%
Poorly correlated
N/A
MEPDF - PDRX
0%
Poorly correlated
N/A
More